Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2CNS 1

Conditions

Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Paclitaxel 161Fulvestrant 155Trastuzumab 152pembrolizumab 144Letrozole 136Carboplatin 118pertuzumab 104Cyclophosphamide 102Capecitabine 102Specimen Handling 101Anastrozole 90palbociclib 85abemaciclib 81Magnetic Resonance Spectroscopy 81exemestane 76Docetaxel 76Tamoxifen 75ribociclib 73trastuzumab deruxtecan 69Radiotherapy 61Biopsy 59Surveys and Questionnaires 56Gemcitabine 52130-nm albumin-bound paclitaxel 52sacituzumab govitecan 50olaparib 50Standard of Care 49Blood Specimen Collection 49Taxes 47Doxorubicin 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
fisetin × Breast × 1 year × Clear all
NCT06113016 2025-07-08

PROFFi

Jonsson Comprehensive Cancer Center

Phase 2 Recruiting
164 enrolled
Breast

Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8

NCT05595499 2025-07-02

Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors

Jonsson Comprehensive Cancer Center

Phase 2 Recruiting
88 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡